Newsletter | June 23, 2022

06.23.22 -- EMA Accepts Sandoz's Proposed High Concentration Formulation of Humira Biosimilar

Featured Editorial
Industry Insights
Gliding Toward De-Risked Combination Product Development

Discover how a new product’s role is critical in determining combination products’ exposure to extractables and leachables.

Gaps In Traditional Reconstitution Process Filled By Water-For-Injection Syringe

The recent rise in biopharmaceutical drugs has sparked renewed interest in lyophilization as a way to bring injectable biologics and other drugs to market faster.

Fundamentals Of Size-Exclusion Chromatography
Size-exclusion chromatography (SEC), also known as gel filtration, can be used for preparative and analytical studies of your protein. But how do you know which parameters give you the best resolution of your protein mixture?
CDMO Collaboration: Foundation For Sterile Injectable Product Success

Explore how a small or midsize biotech or pharma company developing sterile injectables can benefit from the experience and assistance provided by a CDMO.

Guide Clients Through Drug Development With Intelligent Collaboration

This article recaps a recent discussion with the general manager of Pfizer CentreOne, regarding what it’s like to lead an embedded CDMO within one of the largest pharmaceutical companies.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.